List of Tables
Table 1. Global Peroxiredoxin 2 Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peroxiredoxin 2 Monoclonal Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peroxiredoxin 2 Monoclonal Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peroxiredoxin 2 Monoclonal Antibody Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peroxiredoxin 2 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peroxiredoxin 2 Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peroxiredoxin 2 Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peroxiredoxin 2 Monoclonal Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peroxiredoxin 2 Monoclonal Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Peroxiredoxin 2 Monoclonal Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peroxiredoxin 2 Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peroxiredoxin 2 Monoclonal Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peroxiredoxin 2 Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peroxiredoxin 2 Monoclonal Antibody Sales by Region (2020-2025) & (K Units)
Table 18. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Peroxiredoxin 2 Monoclonal Antibody Sales by Region (2026-2031) & (K Units)
Table 20. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Peroxiredoxin 2 Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Peroxiredoxin 2 Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Peroxiredoxin 2 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
Table 27. North America Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
Table 28. North America Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peroxiredoxin 2 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peroxiredoxin 2 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peroxiredoxin 2 Monoclonal Antibody Sales (K Units) by Type (2020-2025)
Table 51. Global Peroxiredoxin 2 Monoclonal Antibody Sales (K Units) by Type (2026-2031)
Table 52. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Peroxiredoxin 2 Monoclonal Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peroxiredoxin 2 Monoclonal Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Peroxiredoxin 2 Monoclonal Antibody Price (US$/Unit) by Type (2020-2025)
Table 59. Global Peroxiredoxin 2 Monoclonal Antibody Price (US$/Unit) by Type (2026-2031)
Table 60. Global Peroxiredoxin 2 Monoclonal Antibody Sales (K Units) by Application (2020-2025)
Table 61. Global Peroxiredoxin 2 Monoclonal Antibody Sales (K Units) by Application (2026-2031)
Table 62. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Peroxiredoxin 2 Monoclonal Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peroxiredoxin 2 Monoclonal Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Peroxiredoxin 2 Monoclonal Antibody Price (US$/Unit) by Application (2020-2025)
Table 69. Global Peroxiredoxin 2 Monoclonal Antibody Price (US$/Unit) by Application (2026-2031)
Table 70. LifeSpan BioSciences, Inc Company Information
Table 71. LifeSpan BioSciences, Inc Description and Business Overview
Table 72. LifeSpan BioSciences, Inc Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. LifeSpan BioSciences, Inc Peroxiredoxin 2 Monoclonal Antibody Product
Table 74. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 75. Thermo Fisher Company Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Peroxiredoxin 2 Monoclonal Antibody Product
Table 79. Thermo Fisher Recent Developments/Updates
Table 80. RayBiotech, Inc. Company Information
Table 81. RayBiotech, Inc. Description and Business Overview
Table 82. RayBiotech, Inc. Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. RayBiotech, Inc. Peroxiredoxin 2 Monoclonal Antibody Product
Table 84. RayBiotech, Inc. Recent Developments/Updates
Table 85. MyBiosource, Inc. Company Information
Table 86. MyBiosource, Inc. Description and Business Overview
Table 87. MyBiosource, Inc. Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. MyBiosource, Inc. Peroxiredoxin 2 Monoclonal Antibody Product
Table 89. MyBiosource, Inc. Recent Developments/Updates
Table 90. Shanghai Korain Biotech Co., Ltd. Company Information
Table 91. Shanghai Korain Biotech Co., Ltd. Description and Business Overview
Table 92. Shanghai Korain Biotech Co., Ltd. Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Shanghai Korain Biotech Co., Ltd. Peroxiredoxin 2 Monoclonal Antibody Product
Table 94. Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
Table 95. Wuhan Fine Biotech Co., Ltd. Company Information
Table 96. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 97. Wuhan Fine Biotech Co., Ltd. Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Wuhan Fine Biotech Co., Ltd. Peroxiredoxin 2 Monoclonal Antibody Product
Table 99. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 100. CUSABIO Company Information
Table 101. CUSABIO Description and Business Overview
Table 102. CUSABIO Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. CUSABIO Peroxiredoxin 2 Monoclonal Antibody Product
Table 104. CUSABIO Recent Developments/Updates
Table 105. Boster Biological Technology Company Information
Table 106. Boster Biological Technology Description and Business Overview
Table 107. Boster Biological Technology Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Boster Biological Technology Peroxiredoxin 2 Monoclonal Antibody Product
Table 109. Boster Biological Technology Recent Developments/Updates
Table 110. Biomatik Company Information
Table 111. Biomatik Description and Business Overview
Table 112. Biomatik Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Biomatik Peroxiredoxin 2 Monoclonal Antibody Product
Table 114. Biomatik Recent Developments/Updates
Table 115. Assay Genie Company Information
Table 116. Assay Genie Description and Business Overview
Table 117. Assay Genie Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Assay Genie Peroxiredoxin 2 Monoclonal Antibody Product
Table 119. Assay Genie Recent Developments/Updates
Table 120. Abbexa Company Information
Table 121. Abbexa Description and Business Overview
Table 122. Abbexa Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Abbexa Peroxiredoxin 2 Monoclonal Antibody Product
Table 124. Abbexa Recent Developments/Updates
Table 125. CLOUD-CLONE CORP. Company Information
Table 126. CLOUD-CLONE CORP. Description and Business Overview
Table 127. CLOUD-CLONE CORP. Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. CLOUD-CLONE CORP. Peroxiredoxin 2 Monoclonal Antibody Product
Table 129. CLOUD-CLONE CORP. Recent Developments/Updates
Table 130. Innovative Research Company Information
Table 131. Innovative Research Description and Business Overview
Table 132. Innovative Research Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Innovative Research Peroxiredoxin 2 Monoclonal Antibody Product
Table 134. Innovative Research Recent Developments/Updates
Table 135. ZodelBiotec Ltd. Company Information
Table 136. ZodelBiotec Ltd. Description and Business Overview
Table 137. ZodelBiotec Ltd. Peroxiredoxin 2 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. ZodelBiotec Ltd. Peroxiredoxin 2 Monoclonal Antibody Product
Table 139. ZodelBiotec Ltd. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Peroxiredoxin 2 Monoclonal Antibody Distributors List
Table 143. Peroxiredoxin 2 Monoclonal Antibody Customers List
Table 144. Peroxiredoxin 2 Monoclonal Antibody Market Trends
Table 145. Peroxiredoxin 2 Monoclonal Antibody Market Drivers
Table 146. Peroxiredoxin 2 Monoclonal Antibody Market Challenges
Table 147. Peroxiredoxin 2 Monoclonal Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peroxiredoxin 2 Monoclonal Antibody
Figure 2. Global Peroxiredoxin 2 Monoclonal Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peroxiredoxin 2 Monoclonal Antibody Market Share by Type: 2024 & 2031
Figure 4. Recombinant Product Picture
Figure 5. Non-recombinant Product Picture
Figure 6. Global Peroxiredoxin 2 Monoclonal Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Peroxiredoxin 2 Monoclonal Antibody Market Share by Application: 2024 & 2031
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Other
Figure 14. Global Peroxiredoxin 2 Monoclonal Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Peroxiredoxin 2 Monoclonal Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global Peroxiredoxin 2 Monoclonal Antibody Sales (2020-2031) & (K Units)
Figure 17. Global Peroxiredoxin 2 Monoclonal Antibody Average Price (US$/Unit) & (2020-2031)
Figure 18. Peroxiredoxin 2 Monoclonal Antibody Report Years Considered
Figure 19. Peroxiredoxin 2 Monoclonal Antibody Sales Share by Manufacturers in 2024
Figure 20. Global Peroxiredoxin 2 Monoclonal Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Peroxiredoxin 2 Monoclonal Antibody Players: Market Share by Revenue in Peroxiredoxin 2 Monoclonal Antibody in 2024
Figure 22. Peroxiredoxin 2 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Peroxiredoxin 2 Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Peroxiredoxin 2 Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Peroxiredoxin 2 Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Peroxiredoxin 2 Monoclonal Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of Peroxiredoxin 2 Monoclonal Antibody by Type (2020-2031)
Figure 56. Global Peroxiredoxin 2 Monoclonal Antibody Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Peroxiredoxin 2 Monoclonal Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of Peroxiredoxin 2 Monoclonal Antibody by Application (2020-2031)
Figure 59. Global Peroxiredoxin 2 Monoclonal Antibody Price (US$/Unit) by Application (2020-2031)
Figure 60. Peroxiredoxin 2 Monoclonal Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
